(S)-1-Benzyl-2-acetylpyrrolidine | 138052-86-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (S)-1-Benzyl-2-acetylpyrrolidine
• 英文别名: (S)-1-(1-benzylpyrrolidin-2-yl)ethanone；1-[(2S)-1-benzylpyrrolidin-2-yl]ethanone
• CAS: 138052-86-5
• 化学式: C₁₃H₁₇NO
• 分子量: 203.284
• InChiKey: NJPGHZBVAGZDCV-ZDUSSCGKSA-N

物化性质

• 沸点：
  297.8±33.0 °C(Predicted)
• 密度：
  1.073±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  15
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.46
• 拓扑面积：
  20.3
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  (S)-1-Benzyl-2-acetylpyrrolidine 在 盐酸 、 叔丁基锂 作用下， 以 四氢呋喃 、 水 为溶剂， 反应 4.25h， 生成 (S)-α-Methyl-α-acetyl-1-benzyl-2(S)-pyrrolidinemethanol
  参考文献：
  名称：

  The first enantioselective total syntheses of the allopumiliotoxin A alkaloids 267A and 339B

  摘要：

  Short, highly stereocontrolled, asymmetric total synthesis of the title amphibian alkaloids are described. In the first stage the indolizidine ketone 11 is assembled from L-proline in enantiomerically pure form. This short sequence proceeds in five laboratory operations and involves the novel intermediacy of an "unprotected" 2-acylpyrrolidine intermediate (Scheme VII). The (Z)-alkylidene side chain of the target alkaloids are introduced by stereocontrolled aldol dehydration sequences (Schemes X and XI). These enantioselective total syntheses confirm the structures and absolute configurations of the allopumiliotoxins 267A and 339B.

  DOI：

  10.1021/jo00030a026
• 作为产物：
  描述：

  1-苄基-L-脯氨酸 在 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 、 N,N-二异丙基乙胺 作用下， 以 乙醚 、 二氯甲烷 为溶剂， 反应 3.17h， 生成 (S)-1-Benzyl-2-acetylpyrrolidine
  参考文献：
  名称：

  Preparation of Fluoroalkenes via the Shapiro Reaction: Direct Access to Fluorinated Peptidomimetics

  摘要：

  Fluoroalkenes represent a useful class of peptidomimetics with distinct biophysical properties. Current preparations of this functional group commonly provide mixtures of E- or Z-fluoroalkene diastereomers, and/or mixtures of nonfluorinated products. To directly access fluoroalkenes in good stereoselectivity, a Shapiro fluorination reaction was developed. Fluoroalkene products were accessed in one- or two-step sequences from widely available ketones. This strategy should be useful for the preparation of fluorinated analogs of peptide-based therapeutics, many of which would be challenging to prepare by alternate strategies.

  DOI：

  10.1021/ol401637n

文献信息

• Macrocyclic Compounds And Methods Of Making And Using The Same
  申请人：Farmer J. Jay

  公开号：US20080045585A1

  公开（公告）日：2008-02-21

  The present invention provides macrocyclic compounds useful as therapeutic agents. More particularly, these compounds are useful as anti-infective, anti-proliferative, anti-inflammatory, and prokinetic agents.

  本发明提供了一种用作治疗剂的大环化合物。更具体地说，这些化合物可用作抗感染、抗增殖、抗炎和促动力剂。
• Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
  申请人：Getman P. Daniel

  公开号：US20070004646A1

  公开（公告）日：2007-01-04

  Selected heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide compounds are effective as retroviral protease inhibitors, and in particular as inhibitors of HIV protease. The present invention relates to such retroviral protease inhibitors and, more particularly, relates to selected novel compounds, compositions, and methods for inhibiting retroviral proteases, such as human immunodeficiency virus (HIV) protease, prophylactically preventing retroviral infection or the spread of a retrovirus, and treatment of a retroviral infection.

  选择性杂环羰基氨基酸羟乙基氨磺酰胺化合物可作为逆转录病毒蛋白酶抑制剂，特别是作为HIV蛋白酶抑制剂。本发明涉及这种逆转录病毒蛋白酶抑制剂，更具体地涉及选择性新化合物、组合物和方法，用于抑制逆转录病毒蛋白酶，如人类免疫缺陷病毒（HIV）蛋白酶，预防逆转录病毒感染或逆转录病毒的传播，并治疗逆转录病毒感染。
• MACROCYCLIC COMPOUNDS AND METHODS OF MAKING AND USING THE SAME
  申请人：Farmer Jay J.

  公开号：US20120252747A1

  公开（公告）日：2012-10-04

  The present invention provides macrocyclic compounds useful as therapeutic agents of the formula: or a pharmaceutically acceptable salt, ester, N-oxide, or prodrug thereof, wherein T, R 1 , R 2 , R 3 , D, E, F, and G are as defined herein. More particularly, these compounds are useful as anti-infective, antiproliferative, anti-inflammatory and prokinetic agents.

  本发明提供了通式为的大环化合物，可用作治疗剂，或其药学上可接受的盐、酯、N-氧化物或前药，其中T、R1、R2、R3、D、E、F和G如本文所定义。更具体地，这些化合物可用作抗感染、抗增殖、抗炎和促动力剂。
• US8202843B2
  申请人：——

  公开号：US8202843B2

  公开（公告）日：2012-06-19
• US8841263B2
  申请人：——

  公开号：US8841263B2

  公开（公告）日：2014-09-23